- Conceptual and terminological confusion around Personalised Medicine: a coping strategy.Giovanni De Grandis & Vidar Halgunset - 2016 - BMC Medical Ethics 17 (1):1-12.details
|
|
Stem Cell Research and Economic Promises.Timothy Caulfield - 2010 - Journal of Law, Medicine and Ethics 38 (2):303-313.details
|
|
“Neurohype” and the Name Game: Who's to Blame?Timothy Caulfield, Christen Rachul & Amy Zarzeczny - 2010 - American Journal of Bioethics Neuroscience 1 (2):13-15.details
|
|
Neglected ethical issues in biobank management: Results from a U.S. study.R. Jean Cadigan, Dragana Lassiter, Kaaren Haldeman, Ian Conlon, Erik Reavely & Gail E. Henderson - 2013 - Life Sciences, Society and Policy 9 (1).details
|
|
Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications.Shelly Benjaminy & Tania Bubela - 2014 - BMC Medical Ethics 15 (1):58.details
|
|
Stem Cell Research and Economic Promises.Timothy Caulfield - 2010 - Journal of Law, Medicine and Ethics 38 (2):303-313.details
|
|
Personalised Medicine: A Critique on the Future of Health Care. [REVIEW]Jacqueline Savard - 2013 - Journal of Bioethical Inquiry 10 (2):197-203.details
|
|
Hype and Public Trust in Science.Zubin Master & David B. Resnik - 2013 - Science and Engineering Ethics 19 (2):321-335.details
|
|
Towards a bioethics of innovation.Wendy Lipworth & Renata Axler - 2016 - Journal of Medical Ethics 42 (7):445-449.details
|
|
Impediments to “T2” Research: Are Ethics Really to Blame?Wendy Lipworth & Ian Kerridge - 2010 - American Journal of Bioethics 10 (8):39-40.details
|
|
Understanding the Problem of “Hype”: Exaggeration, Values, and Trust in Science.Kristen Intemann - 2022 - Canadian Journal of Philosophy 52 (3):279-294.details
|
|